Armata Pharmaceuticals (ARMP) Preferred Stock Liabilities (2013 - 2016)

Armata Pharmaceuticals (ARMP) has 4 years of Preferred Stock Liabilities data on file, last reported at $91000.0 in Q1 2016.

• For the quarter ending Q1 2016, Preferred Stock Liabilities fell 99.53% year-over-year to $91000.0; the trailing twelve-month figure through Mar 2016 stood at $91000.0 (down 99.53% YoY), and the FY2015 full-year result was $11.9 million, down 3.49% from the prior year.
• Preferred Stock Liabilities retreated to $91000.0 in Q1 2016, from $11.9 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $46.3 million in Q1 2014 to a low of $91000.0 in Q1 2016.
• A 4-year average of $15.0 million and a median of $12.1 million in 2014 frame the typical range for Preferred Stock Liabilities.
• Across the five-year window, Preferred Stock Liabilities jumped 1642.57% in 2014 and sank 99.53% in 2016, its largest moves.
• Tracing ARMP's Preferred Stock Liabilities over 4 years: stood at $707000.0 in 2013, then jumped by 1642.57% to $12.3 million in 2014, then declined by 3.49% to $11.9 million in 2015, then tumbled by 99.23% to $91000.0 in 2016.
• Business Quant data shows ARMP's Preferred Stock Liabilities at $91000.0 in Q1 2016, $11.9 million in Q4 2015, and $2.1 million in Q3 2015.